Cancers (Feb 2021)

Surveillance as Determinant of Long-Term Survival in Non-Transplanted Hepatocellular Carcinoma Patients

  • Filippo Pelizzaro,
  • Alessandro Vitale,
  • Anna Sartori,
  • Andrea Vieno,
  • Barbara Penzo,
  • Francesco Paolo Russo,
  • Anna Chiara Frigo,
  • Edoardo G Giannini,
  • Manuela Piccinnu,
  • Gian Ludovico Rapaccini,
  • Maria Di Marco,
  • Eugenio Caturelli,
  • Marco Zoli,
  • Rodolfo Sacco,
  • Ciro Celsa,
  • Fabio Marra,
  • Andrea Mega,
  • Maria Guarino,
  • Antonio Gasbarrini,
  • Gianluca Svegliati-Baroni,
  • Francesco Giuseppe Foschi,
  • Andrea Olivani,
  • Alberto Masotto,
  • Pietro Coccoli,
  • Giovanni Raimondo,
  • Francesco Azzaroli,
  • Gianpaolo Vidili,
  • Maurizia Rossana Brunetto,
  • Franco Trevisani,
  • Fabio Farinati,
  • on behalf of ITA.LI.CA Study Group

DOI
https://doi.org/10.3390/cancers13040897
Journal volume & issue
Vol. 13, no. 4
p. 897

Abstract

Read online

Purpose: We aimed at assessing the impact of surveillance on long-term survival in HCC patients. Methods: From the ITA.LI.CA database, we selected 1028 cases with long (≥5 years, LS group) and 2721 controls with short-term survival (p p p p = 0.0008, respectively). In IPW adjusted populations, no survival differences were demonstrated between the two groups (p = 0.30). Conclusions: Surveillance, increasing early-stage diagnosis and applicability of curative treatments, is a fundamental determinant of long-term survival in HCC patients. A wide implementation of surveillance programs should be pursued in order to improve HCC patients’ prognosis.

Keywords